26 June 2019 – Abstract submission is now open for the 34th International Conference of Alzheimer's Disease International (ADI), to take place in Singapore in March 2020. [read more]
17 June 2019 – The government of Canada today adopted a national plan on dementia. The plan is the 32nd to be adopted worldwide, and includes key targets for improving awareness, access to care, support and treatment, research and risk reduction of dementia by 2025. [read more]
21 May 2019 – ADI's new report, From Plan to Impact II: the urgent need for action, has been published to mark the 2nd anniversary of the adoption of the World Health Organization (WHO) Global plan on the public health response to dementia 2017-2025. [read more]
15 May 2019 – ADI's Chief Executive Paola Barbarino presented Her Majesty Queen Sofía of Spain with an award for becoming ADI’s Global Ambassador at the 3rd Dementia Forum X meeting at the Royal Palace of Stockholm. [read more]
9 May 2019 – A pioneering new report by ADI, The Global Alzheimer’s & Dementia Action Alliance (GADAA) and Alzheimer's Pakistan has revealed that people with dementia are being ignored in times of humanitarian crisis. [read more]
3 May 2019 - A paper published in the journal Brain (30 April 2019) has identified a brain disorder that appears to mimic the clinical features of Alzheimer’s disease. Known as LATE (Limbic-predominant Age-related TDP-43 Encephalopathy) it appears to be linked to the accumulation of a protein, TDP-43, in the brain, while Alzheimer's disease is more commonly linked to two other brain proteins - amyloid and tau. [read more]
1 May 2019 - Alzheimer's Disease International (ADI) is delighted to invite you to a side event at the 72nd World Health Assembly, moderated by Chief Executive Paola Barbarino. [read more]
15 April 2019 – ADI's survey on attitudes around dementia is now open and we want to hear what YOU think. The survey will form the basis for the World Alzheimer Report 2019, to be released in September. It will only take around 10 minutes of your time but completing it will benefit people with dementia all over the world. [Read more]
3 April 2019 – ADI's Chief Executive Paola Barbarino presented Her Majesty Queen Silvia of Sweden with an award for becoming ADI’s Global Ambassador at the Jubilee event for the Queen Silvia Nursing Award at the Royal Palace of Stockholm. [read more]
22 March 2019 – Pharmaceutical companies Biogen and Eisai have announced the discontinuation of two Phase 3 trials of aducanumab. The decision came after analysis by an independent monitoring committee indicated the trials were unlikely to succeed. Biogen and Eisai will continue to investigate other treatments for Alzheimer’s disease, including anti-amyloid treatment BAN2401. [read more]
![[About ADI]](/sites/default/files/button_about_adi.png)
![[List of Alzheimer associations]](/sites/default/files/button_list_association.png)
![[Instagram]](/sites/default/files/1_instagram_48x48.png)
![[LinkedIn]](/sites/default/files/12linkedin48x48.png)
![[YouTube]](/sites/default/files/12youtube48x48.png)
![[Twitter]](/sites/default/files/1264105200_Twitter_48x48.png)
![[Facebook]](/sites/default/files/1264105185_FaceBook_48x48.png)